{"id":27512,"date":"2019-06-06T15:28:38","date_gmt":"2019-06-06T18:28:38","guid":{"rendered":"https:\/\/www.suno.com.br\/noticias\/?p=27512"},"modified":"2019-06-06T18:35:47","modified_gmt":"2019-06-06T21:35:47","slug":"brasil-pharma-falencia-acoes","status":"publish","type":"post","link":"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/","title":{"rendered":"Brasil Pharma planeja discutir pedido de fal\u00eancia e cai 45% na Bolsa"},"content":{"rendered":"<p>A Brasil Pharma (BPHA3) publicou fato relevante nesta quinta-feira (6) convocando <strong>Assembleia Geral Extraordin\u00e1ria<\/strong> (AGE) para acionistas discutirem o pedido de <a href=\"https:\/\/www.suno.com.br\/artigos\/falencia\/\"><strong>fal\u00eancia<\/strong><\/a>, que foi aprovado pelo Conselho de Administra\u00e7\u00e3o da empresa.<\/p>\t<div class=\"wrapper-featured-image\">\n\t\t<figure class=\"spotlightImg\">\n\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 768px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/06\/4b47c800-brasil-pharma-400x200.webp\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"newsContent__article__imgCapa lazyloadDisabled newsContent__article__imgCapa--noCaption\" src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/06\/4b47c800-brasil-pharma-800x450.webp\" width=\"800\" height=\"450\" alt=\"Brasil Pharma planeja discutir pedido de fal\u00eancia e cai 45% na Bolsa\" fetchpriority=high \/>\n\t\t\t<\/picture>\n\n\t\t\t<figcaption class=\"wp-caption-text wp-caption-text--hide\">Brasil Pharma deve discutir pedido de fal\u00eancia. (divulga\u00e7\u00e3o)<\/figcaption>\n\t\t<\/figure>\n\t<\/div>\n\n\n<p>As negocia\u00e7\u00f5es dos papeis foram suspensas at\u00e9 \u00e0s 11h pela <strong><a href=\"https:\/\/www.suno.com.br\/artigos\/b3\/\">B3<\/a><\/strong> (Brasil, Bolsa, Balc\u00e3o) ap\u00f3s o informe. \u00c0s 15h08, as <strong><a href=\"https:\/\/www.suno.com.br\/artigos\/acoes-ordinarias\/\">a\u00e7\u00f5es ordin\u00e1rias<\/a><\/strong> (ON) da <strong>Brasil Pharma<\/strong> ca\u00edam 45,65% a R$\u00a00,75. No fechamento, entretanto, as perdas foram contidas a 36,96% (R$\u00a00,87).<\/p>\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/ao\/sessao-estrategica-consultoria-c\/?utm_source=suno-noticias&#038;utm_medium=banner&#038;utm_campaign=_SNC36CE4E9F_&#038;utm_content=fundos-imobiliarios-ou-imoveis-onde-investir-500-mil-go\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2025\/09\/300x400.webp\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2025\/09\/SN-DT-1420x240-1.webp\"\n\t\t\t\t\tdata-promo-id=\"635171\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='240'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2025\/09\/SN-DT-1420x240-1.webp\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n<p>A Brasil Pharma realizou o pedido de <a href=\"https:\/\/www.suno.com.br\/artigos\/recuperacao-judicial\/\">recupera\u00e7\u00e3o judicial<\/a> \u00e0\u00a0<strong>2\u00aa Vara de Fal\u00eancias e Recupera\u00e7\u00f5es Judiciais da Comarca de S\u00e3o Paulo<\/strong> em janeiro de 2018.<\/p>\n<p>O plano de <strong>recupera\u00e7\u00e3o judicial<\/strong> foi homologado em novembro de 2018. Contudo, de acordo com a empresa,\u00a0o plano &#8220;foi severamente afetado por diversos fatores e intercorr\u00eancias nos \u00faltimos meses. Que acabaram por comprometer o prosseguimento da recupera\u00e7\u00e3o judicial e tornaram ineficazes as medidas visando \u00e0 solu\u00e7\u00e3o da persistente <strong>crise econ\u00f4mico-financeira<\/strong> da companhia&#8221;.<\/p>\n<p>A empresa destacou os seguintes fatores:<\/p>\n<ul>\n<li>o baixo valor arrecadado nos <strong>leil\u00f5es<\/strong> de mercadoria e ativos conduzidos nos termos do plano de <strong>recupera\u00e7\u00e3o judicial<\/strong>;<\/li>\n<li>a r\u00e1pida queda do valor de mercado dos pontos comerciais, avaliados em cerca de R$ 55 milh\u00f5es de reais. Isto ocorreu em fun\u00e7\u00e3o de in\u00fameras <strong>a\u00e7\u00f5es judiciais<\/strong> para retomada dos im\u00f3veis, e n\u00e3o amparadas pelo benef\u00edcio da recupera\u00e7\u00e3o judicial;<\/li>\n<li>e a <strong>suspens\u00e3o do leil\u00e3o<\/strong> da rede de drogarias \u201cFarmais\u201d,\u00a0que impediu a aliena\u00e7\u00e3o do ativo mais relevante, avaliado no plano de recupera\u00e7\u00e3o judicial em R$ 150 milh\u00f5es.<\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.suno.com.br\/noticias\/justica-suspende-venda-farmais-pharma\/\">Saiba mais &#8211;\u00a0Venda da Farmais, da BR Pharma, \u00e9 suspensa pela Justi\u00e7a<\/a><\/p>\n<h2>Suspens\u00e3o do plano de recupera\u00e7\u00e3o judicial da Brasil Pharma<\/h2>\n<p>Em 6 de mar\u00e7o de 2019, a <strong>Panpharma\u00a0<\/strong>obteve liminar em segunda inst\u00e2ncia que suspendeu o plano de recupera\u00e7\u00e3o judicial da varejista.<\/p>\n<p>No pedido de liminar, a Panpharma, que \u00e9 credora da Brasil Pharma:<\/p>\n<ul>\n<li>questionou a atua\u00e7\u00e3o do grupo <strong>BTG Pactual\u00a0<\/strong>(BPAC11), o antigo controlador da varejista;<\/li>\n<li>mencionou a venda da <strong>Brasil Pharma<\/strong> para o empres\u00e1rio <strong>Paulo Remy<\/strong>, em 2017;<\/li>\n<li>al\u00e9m de citar <strong>conflito de interesse<\/strong> de s\u00f3cios do BTG Pactual, credores da rede.<\/li>\n<\/ul>\n<p><a href=\"https:\/\/storage.googleapis.com\/wp-noticias\/2019\/06\/a24d4114-22500_694327.-1.pdf\">Clique aqui<\/a> e confira o fato relevante da <strong>Brasil Pharma<\/strong> na \u00edntegra.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Brasil Pharma (BPHA3) publicou fato relevante nesta quinta-feira (6) convocando Assembleia Geral Extraordin\u00e1ria (AGE) para acionistas discutirem o pedido de fal\u00eancia, que foi aprovado pelo Conselho de Administra\u00e7\u00e3o da empresa. Brasil Pharma deve discutir pedido de fal\u00eancia. (divulga\u00e7\u00e3o) As negocia\u00e7\u00f5es dos papeis foram suspensas at\u00e9 \u00e0s 11h pela B3 (Brasil, Bolsa, Balc\u00e3o) ap\u00f3s o [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":27514,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[64],"tags":[979],"suno_strategy":[],"class_list":["post-27512","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-negocios","tag-falencia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Brasil Pharma planeja discutir pedido de fal\u00eancia e cai 45% na Bolsa<\/title>\n<meta name=\"description\" content=\"As a\u00e7\u00f5es da Brasil Pharma (BPHA3) caem 44% ap\u00f3s a empresa convocar assembleia para discutir pedido de fal\u00eancia. Clique para saber mais.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Brasil Pharma planeja discutir pedido de fal\u00eancia e cai 45% na Bolsa\" \/>\n<meta property=\"og:description\" content=\"As a\u00e7\u00f5es da Brasil Pharma (BPHA3) caem 44% ap\u00f3s a empresa convocar assembleia para discutir pedido de fal\u00eancia. Clique para saber mais.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/\" \/>\n<meta property=\"og:site_name\" content=\"Suno Not\u00edcias\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/sunoresearch\" \/>\n<meta property=\"og:image\" content=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/06\/4b47c800-brasil-pharma.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"960\" \/>\n\t<meta property=\"og:image:height\" content=\"635\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Amanda Gushiken\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@sunoresearch\" \/>\n<meta name=\"twitter:site\" content=\"@sunoresearch\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Amanda Gushiken\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/\"},\"author\":{\"name\":\"Amanda Gushiken\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/a5b06fa4e879d8e8e119c6ed3cd630d1\"},\"headline\":\"Brasil Pharma planeja discutir pedido de fal\u00eancia e cai 45% na Bolsa\",\"datePublished\":\"2019-06-06T18:28:38+00:00\",\"dateModified\":\"2019-06-06T21:35:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/\"},\"wordCount\":393,\"publisher\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/06\/4b47c800-brasil-pharma-jpg.webp\",\"keywords\":[\"fal\u00eancia\"],\"articleSection\":[\"Neg\u00f3cios\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/\",\"name\":\"Brasil Pharma planeja discutir pedido de fal\u00eancia e cai 45% na Bolsa\",\"isPartOf\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/06\/4b47c800-brasil-pharma-jpg.webp\",\"datePublished\":\"2019-06-06T18:28:38+00:00\",\"dateModified\":\"2019-06-06T21:35:47+00:00\",\"description\":\"As a\u00e7\u00f5es da Brasil Pharma (BPHA3) caem 44% ap\u00f3s a empresa convocar assembleia para discutir pedido de fal\u00eancia. Clique para saber mais.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/#primaryimage\",\"url\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/06\/4b47c800-brasil-pharma-jpg.webp\",\"contentUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/06\/4b47c800-brasil-pharma-jpg.webp\",\"width\":960,\"height\":635,\"caption\":\"Brasil Pharma deve discutir pedido de fal\u00eancia. (divulga\u00e7\u00e3o)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Not\u00edcias\",\"item\":\"https:\/\/www.suno.com.br\/noticias\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neg\u00f3cios\",\"item\":\"https:\/\/www.suno.com.br\/noticias\/negocios\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Brasil Pharma planeja discutir pedido de fal\u00eancia e cai 45% na Bolsa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#website\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/\",\"name\":\"Suno Not\u00edcias\",\"description\":\"Seu portal de informa\u00e7\u00e3o sobre o mundo dos investimentos\",\"publisher\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.suno.com.br\/noticias\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\",\"name\":\"Suno Not\u00edcias\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png\",\"contentUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png\",\"width\":180,\"height\":180,\"caption\":\"Suno Not\u00edcias\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/facebook.com\/sunoresearch\",\"https:\/\/x.com\/sunoresearch\",\"https:\/\/www.instagram.com\/suno\",\"https:\/\/www.linkedin.com\/company\/suno-research\/\",\"https:\/\/www.youtube.com\/c\/sunoresearch\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/a5b06fa4e879d8e8e119c6ed3cd630d1\",\"name\":\"Amanda Gushiken\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ecd84705e6b65e3685ae80d725501fbe?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ecd84705e6b65e3685ae80d725501fbe?s=96&r=g\",\"caption\":\"Amanda Gushiken\"},\"description\":\"Amanda Sayuri Gushiken escreve sobre finan\u00e7as e neg\u00f3cios para o portal Suno Not\u00edcias. Antes, trabalhou selecionando not\u00edcias da imprensa para clientes do mercado financeiro. Tamb\u00e9m desenvolveu pesquisa acad\u00eamica pela Universidade Anhembi Morumbi na \u00e1rea de Teorias da Comunica\u00e7\u00e3o e \u00e9 fot\u00f3grafa nas horas vagas.\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/author\/amanda\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Brasil Pharma planeja discutir pedido de fal\u00eancia e cai 45% na Bolsa","description":"As a\u00e7\u00f5es da Brasil Pharma (BPHA3) caem 44% ap\u00f3s a empresa convocar assembleia para discutir pedido de fal\u00eancia. Clique para saber mais.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/","og_locale":"pt_BR","og_type":"article","og_title":"Brasil Pharma planeja discutir pedido de fal\u00eancia e cai 45% na Bolsa","og_description":"As a\u00e7\u00f5es da Brasil Pharma (BPHA3) caem 44% ap\u00f3s a empresa convocar assembleia para discutir pedido de fal\u00eancia. Clique para saber mais.","og_url":"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/","og_site_name":"Suno Not\u00edcias","article_publisher":"https:\/\/facebook.com\/sunoresearch","og_image":[{"width":960,"height":635,"url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/06\/4b47c800-brasil-pharma.jpg","type":"image\/jpeg"}],"author":"Amanda Gushiken","twitter_card":"summary_large_image","twitter_creator":"@sunoresearch","twitter_site":"@sunoresearch","twitter_misc":{"Escrito por":"Amanda Gushiken","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/#article","isPartOf":{"@id":"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/"},"author":{"name":"Amanda Gushiken","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/a5b06fa4e879d8e8e119c6ed3cd630d1"},"headline":"Brasil Pharma planeja discutir pedido de fal\u00eancia e cai 45% na Bolsa","datePublished":"2019-06-06T18:28:38+00:00","dateModified":"2019-06-06T21:35:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/"},"wordCount":393,"publisher":{"@id":"https:\/\/www.suno.com.br\/noticias\/#organization"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/#primaryimage"},"thumbnailUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/06\/4b47c800-brasil-pharma-jpg.webp","keywords":["fal\u00eancia"],"articleSection":["Neg\u00f3cios"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/","url":"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/","name":"Brasil Pharma planeja discutir pedido de fal\u00eancia e cai 45% na Bolsa","isPartOf":{"@id":"https:\/\/www.suno.com.br\/noticias\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/#primaryimage"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/#primaryimage"},"thumbnailUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/06\/4b47c800-brasil-pharma-jpg.webp","datePublished":"2019-06-06T18:28:38+00:00","dateModified":"2019-06-06T21:35:47+00:00","description":"As a\u00e7\u00f5es da Brasil Pharma (BPHA3) caem 44% ap\u00f3s a empresa convocar assembleia para discutir pedido de fal\u00eancia. Clique para saber mais.","breadcrumb":{"@id":"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/#primaryimage","url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/06\/4b47c800-brasil-pharma-jpg.webp","contentUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/06\/4b47c800-brasil-pharma-jpg.webp","width":960,"height":635,"caption":"Brasil Pharma deve discutir pedido de fal\u00eancia. (divulga\u00e7\u00e3o)"},{"@type":"BreadcrumbList","@id":"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Not\u00edcias","item":"https:\/\/www.suno.com.br\/noticias\/"},{"@type":"ListItem","position":2,"name":"Neg\u00f3cios","item":"https:\/\/www.suno.com.br\/noticias\/negocios\/"},{"@type":"ListItem","position":3,"name":"Brasil Pharma planeja discutir pedido de fal\u00eancia e cai 45% na Bolsa"}]},{"@type":"WebSite","@id":"https:\/\/www.suno.com.br\/noticias\/#website","url":"https:\/\/www.suno.com.br\/noticias\/","name":"Suno Not\u00edcias","description":"Seu portal de informa\u00e7\u00e3o sobre o mundo dos investimentos","publisher":{"@id":"https:\/\/www.suno.com.br\/noticias\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.suno.com.br\/noticias\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.suno.com.br\/noticias\/#organization","name":"Suno Not\u00edcias","url":"https:\/\/www.suno.com.br\/noticias\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/","url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png","contentUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png","width":180,"height":180,"caption":"Suno Not\u00edcias"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/sunoresearch","https:\/\/x.com\/sunoresearch","https:\/\/www.instagram.com\/suno","https:\/\/www.linkedin.com\/company\/suno-research\/","https:\/\/www.youtube.com\/c\/sunoresearch"]},{"@type":"Person","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/a5b06fa4e879d8e8e119c6ed3cd630d1","name":"Amanda Gushiken","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ecd84705e6b65e3685ae80d725501fbe?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ecd84705e6b65e3685ae80d725501fbe?s=96&r=g","caption":"Amanda Gushiken"},"description":"Amanda Sayuri Gushiken escreve sobre finan\u00e7as e neg\u00f3cios para o portal Suno Not\u00edcias. Antes, trabalhou selecionando not\u00edcias da imprensa para clientes do mercado financeiro. Tamb\u00e9m desenvolveu pesquisa acad\u00eamica pela Universidade Anhembi Morumbi na \u00e1rea de Teorias da Comunica\u00e7\u00e3o e \u00e9 fot\u00f3grafa nas horas vagas.","url":"https:\/\/www.suno.com.br\/noticias\/author\/amanda\/"}]}},"default_loop_html":"<div class=\"cardsPage__listCard__boxs\"><div class=\"cardsPage__listCard__boxs__img\"><a href=\"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/\"><img class=\"mask\" src=\"https:\/\/www.suno.com.br\/noticias\/wp-content\/themes\/suno\/resources\/images\/spotlight\/spotlight1img\/bg-mask.png\" alt=\"Image Mask\"\/><img src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/06\/4b47c800-brasil-pharma-400x200.webp\" alt=\"Brasil Pharma planeja discutir pedido de fal\u00eancia e cai 45% na Bolsa\"\/><\/a><span class=\"spotlightCategory\"><a href=\"https:\/\/www.suno.com.br\/noticias\/negocios\/\">Neg\u00f3cios<\/a><\/span><\/div><div class=\"cardsPage__listCard__boxs__content\"><a href=\"https:\/\/www.suno.com.br\/noticias\/brasil-pharma-falencia-acoes\/\"><h2 class=\"content__title\">Brasil Pharma planeja discutir pedido de fal\u00eancia e cai 45% na Bolsa<\/h2><\/a><div class=\"newsContent__article__meta\"><div class=\"newsContent__article__meta__authorBox\"><a href=\"https:\/\/www.suno.com.br\/noticias\/author\/amanda\/\" class=\"authorBox__avatar noMobi\"><img src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2018\/11\/c6ad30be-amanda-150x150.webp\" alt=\"Amanda Gushiken\"><\/a><div class=\"authorBox__name\"><span>por\n\t\t\t<a href=\"https:\/\/www.suno.com.br\/noticias\/author\/amanda\/\"><span itemprop=\"author\">Amanda Gushiken<\/span><\/a><\/span><time datetime=\"2019-06-06T15:28:38-03:00\" itemprop=\"datePublished\">06\/06\/2019 15:28<\/time><\/div><\/div><\/div><\/div><\/div>","single_layout":"posts","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/27512"}],"collection":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/comments?post=27512"}],"version-history":[{"count":0,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/27512\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/media\/27514"}],"wp:attachment":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/media?parent=27512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/categories?post=27512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/tags?post=27512"},{"taxonomy":"suno_strategy","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/suno_strategy?post=27512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}